Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.
There is a critical need to identify biomarkers for Systemic Lupus Erythematosus (SLE) which has a high prevalence of renal failure. When urine from patients with lupus nephritis was recently screened for the levels of ∼280 molecules using an exploratory array-based proteomic platform, elevated angiostatin levels were noted. Angiostatin is a bioactive fragment of plasminogen, and has been known to have modulatory function in angiogenesis and inflammation. The significant elevation in urinary angiostatin was next validated in an independent cohort of SLE patients (n = 100) using ELISA. Among patients with SLE, urine angiostatin was significantly increased in active SLE compared with inactive SLE, correlating well with the SLEDAI disease activity index and SLICC renal activity score (r = 0.66, p < 0.0001). ROC curve analysis further confirmed that urinary angiostatin had the capacity to discriminate patients with active SLE from those with inactive disease. Patients with Class IV lupus nephritis exhibited the highest levels of urinary angiostatin. Immunohistochemistry staining localized angiostatin expression to the renal tubular cells in these patients. Finally, when paired urine-kidney samples procured concurrently from patients with LN were next examined, urine angiostatin levels correlated strongly with the renal pathology chronicity index, but not with the activity index. Given that Class IV lupus nephritis and renal pathology chronicity changes forebode poor renal and patient survival, urinary angiostatin emerges as a novel noninvasive marker of renal disease in SLE. Longitudinal studies are in progress to further assess the disease-predictive potential of urinary angiostatin.
Division of Rheumatology, UT Southwestern Medical Center at Dallas, TX 75390, USA. Tianfu.wu@utsouthwestern.edu
Tianfu
T
Wu
Yong
Y
Du
Jie
J
Han
Sandeep
S
Singh
Chun
C
Xie
Yuyuan
Y
Guo
Xin J
XJ
Zhou
Chul
C
Ahn
Ramesh
R
Saxena
Chandra
C
Mohan
D000328:Adult; D000809:Angiotensins / Q000652:urine*; D015415:Biomarkers / Q000652:urine; D016022:Case-Control Studies; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology*; D008181:Lupus Nephritis / Q000652:urine*; D008297:Male; D040081:Protein Array Analysis; D012720:Severity of Illness Index
D000809:Angiotensins; D015415:Biomarkers